Electrospun nanofibrous membranes
are a widely used physical barrier
for reducing postoperative adhesion. However, these physical barriers
could not prevent adhesion formation completely. Because a high-intensity
inflammation occurs in the surgical area, the presence of relevant
drugs to control such an inflammation is desperately needed. In this
study, we fabricated an electrospun composite ibuprofen-loaded poly(ethylene
glycol) (PEG)/polycaprolactone (PCL) nanofibrous membrane (NFM) to
prevent abdominal adhesions. This membrane aimed to act as a barrier
between the abdominal wall and surrounding tissues, without interrupting
mass transfer and normal wound healing. Among various fabricated composite
NFMs, PCL/25PEG-6% NFMs showed the lowest fiber diameter (448.8 ±
124.4 nm), the smallest pore size (<2 μm), and moderate ultimate
stress and strain. The PCL/25PEG-6% NFMs had the lowest water contact
angle (≈75°) and the highest drug profile release (≈80%)
within 14 days. Furthermore, in vitro toxicity examination
of PCL/25PEG-6% toward fibroblast cells demonstrated a cell viability
of ≈82% after 3 days, proving its prolonged antiadhesion ability.
In addition, the low number of adherent cells with a rounded shape
and low cell proliferation on these NFMs indicated their special antiadhesive
effects. Collectively, these results indicated that the PCL/25PEG-6%
membrane might be a suitable barrier to prevent abdominal adhesion.